Tower Research Capital LLC (Trc) Terns Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,411 shares of TERN stock, worth $11,426. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,411
Previous 6,117
44.24%
Holding current value
$11,426
Previous $51,000
62.75%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding TERN
# of Institutions
160Shares Held
83.9MCall Options Held
473KPut Options Held
119K-
Soleus Capital Management, L.P. Greenwich, CT8.14MShares$27.3 Million3.16% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$25.3 Million1.14% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$23.1 Million7.51% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$18.7 Million1.37% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY4.75MShares$15.9 Million0.17% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $126M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...